Insurance Formularies Holding Up Lower-Emission Asthma, COPD Inhalers
(MedPage Today) -- Commercial insurance formularies have posed a barrier to cutting greenhouse gas emissions from metered-dose inhalers used to treat asthma and chronic obstructive pulmonary disease (COPD), a study showed. Lower-emission versions...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.